Sarah Elizabeth Ross
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sarah Elizabeth Ross has a total of 249 co-authors. Here are the top co-authors by number of shared publications:
Eileen Nguyen
University of Pittsburgh School of Medicine, Department of Neurobiology, United States; University of Pittsburgh, Pittsburgh Center for Pain Research, United States; University of California, Department of Anesthesiology, Los Angeles, United States
11 shared publications- Lindsey M. Snyder
Department of Neurobiology and the Pittsburgh Center for Pain Research, University of Pittsburgh, Pittsburgh, PA 15213, USA
10 shared publications - Junichi Hachisuka
School of Psychology and Neuroscience, College of Medical, Veterinary and Life Sciences, University of Glasgow
9 shared publications Kelly M. Smith
Pittsburgh Center for Pain Research and Department of Neurobiology, University of Pittsburgh, Pittsburgh, PA, USA
7 shared publications- Tayler D. Sheahan
University of Pittsburgh
7 shared publications - Charles A. Warwick
Department of Neurobiology, Pittsburgh Center for Pain Research University of Pittsburgh Pittsburgh PA USA
6 shared publications
Latest Publications
- Open Access
- 3 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (27) , eadx5109
Substance P regulates Tacr1 neurons, which control nitric oxide–mediated neurovascular coupling in the mouse cortex
Neuronal activity–driven increases in cerebral blood flow (CBF), known as neurovascular coupling (NVC), are crucial for sustaining the metabolic demands of the brain. Our group has found that Tacr1 neurons, a subset of somatostatin neurons expressing the substance P (SP) receptor and neuronal nitric oxide synthase (nNOS), exert a disproportionately large regulation of CBF. Here, we use two-photon imaging to show that Tacr1 neurons regulate CBF through nitric oxide (NO) release and SP-receptor signaling . We identify astrocytic calcium (Ca 2+ ) transients as a secondary response to vasodilation. To identify potential sources of SP in somatosensory cortex, viral mapping revealed Tac1 -positive neurons locally, predominantly among parvalbumin (PV) neurons, as well as Tac1 -positive long-range projections from perirhinal cortex. Functional analyses indicate that PV neurons regulate CBF through a Tacr1 neuron dependent pathway. These findings suggest a sequential mechanism whereby Tacr1 neurons respond to SP to release NO, inducing vasodilation and driving astrocytic Ca 2+ signaling.
- 3 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (27) , eadx5109
Open AccessSubstance P regulates Tacr1 neurons, which control nitric oxide–mediated neurovascular coupling in the mouse cortex
Neuronal activity–driven increases in cerebral blood flow (CBF), known as neurovascular coupling (NVC), are crucial for sustaining the metabolic demands of the brain. Our group has found that Tacr1 neurons, a subset of somatostatin neurons expressing the substance P (SP) receptor and neuronal nitric oxide synthase (nNOS), exert a disproportionately large regulation of CBF. Here, we use two-photon imaging to show that Tacr1 neurons regulate CBF through nitric oxide (NO) release and SP-receptor signaling . We identify astrocytic calcium (Ca 2+ ) transients as a secondary response to vasodilation. To identify potential sources of SP in somatosensory cortex, viral mapping revealed Tac1 -positive neurons locally, predominantly among parvalbumin (PV) neurons, as well as Tac1 -positive long-range projections from perirhinal cortex. Functional analyses indicate that PV neurons regulate CBF through a Tacr1 neuron dependent pathway. These findings suggest a sequential mechanism whereby Tacr1 neurons respond to SP to release NO, inducing vasodilation and driving astrocytic Ca 2+ signaling.
- 24 January 2026
- Published by Oxford University Press (OUP) in Brain
- Vol. 149 (8) , 2876-2891
Tegmental kappa-opioid receptor neurons modulate opioid withdrawal via the periaqueductal gray
Opioid withdrawal is a common and distressing manifestation of opioid dependence which, if left untreated, frequently results in relapse, accidental overdose, and suicide. While much is known about the role of mesolimbic and mesocortical dopaminergic neurons in mu opioid receptor-mediated reward, much less is understood about the impact of chronic opioid use on parallel aversive pathways mediated by the kappa opioid receptor and its endogenous ligand dynorphin. In the present study, we interrogate kappa opioid receptor-expressing ventral tegmental area neurons and their dynorphinergic inputs in vitro and in vivo, to elucidate the circuit mechanisms by which chronic opioids promote withdrawal behaviors in mice. Through a combination of genetic, molecular, and custom machine learning analytical approaches, we uncovered the effects of chronic morphine on kappa opioid receptor mRNA expression in the ventral tegmental area as well as dynorphin mRNA expression in several retrogradely traced dynorphinergic input regions. We find that chronic morphine exposure diminishes opioid-induced c-Fos expression selectively in midbrain kappa opioid receptor-expressing neurons. In addition, chemogenetic activation of kappa opioid receptor-expressing ventral tegmental area neurons was sufficient to attenuate diverse opioid withdrawal-associated behaviors, negative affect, and gastrointestinal distress in mice. Finally, we uncovered a glutamatergic subpopulation of kappa opioid receptor-expressing ventral tegmental area neurons projecting to the ventrolateral periaqueductal gray which, when activated, selectively relieved opioid withdrawal-associated gastrointestinal distress. These discoveries highlight a critical role for midbrain kappa opioid receptor-expressing neurons and the downstream ventrolateral periaqueductal gray in opioid withdrawal-associated disruption of hedonic homeostasis and gastrointestinal regulation.
- 24 January 2026
- Published by Oxford University Press (OUP) in Brain
- Vol. 149 (8) , 2876-2891
Tegmental kappa-opioid receptor neurons modulate opioid withdrawal via the periaqueductal gray
Opioid withdrawal is a common and distressing manifestation of opioid dependence which, if left untreated, frequently results in relapse, accidental overdose, and suicide. While much is known about the role of mesolimbic and mesocortical dopaminergic neurons in mu opioid receptor-mediated reward, much less is understood about the impact of chronic opioid use on parallel aversive pathways mediated by the kappa opioid receptor and its endogenous ligand dynorphin. In the present study, we interrogate kappa opioid receptor-expressing ventral tegmental area neurons and their dynorphinergic inputs in vitro and in vivo, to elucidate the circuit mechanisms by which chronic opioids promote withdrawal behaviors in mice. Through a combination of genetic, molecular, and custom machine learning analytical approaches, we uncovered the effects of chronic morphine on kappa opioid receptor mRNA expression in the ventral tegmental area as well as dynorphin mRNA expression in several retrogradely traced dynorphinergic input regions. We find that chronic morphine exposure diminishes opioid-induced c-Fos expression selectively in midbrain kappa opioid receptor-expressing neurons. In addition, chemogenetic activation of kappa opioid receptor-expressing ventral tegmental area neurons was sufficient to attenuate diverse opioid withdrawal-associated behaviors, negative affect, and gastrointestinal distress in mice. Finally, we uncovered a glutamatergic subpopulation of kappa opioid receptor-expressing ventral tegmental area neurons projecting to the ventrolateral periaqueductal gray which, when activated, selectively relieved opioid withdrawal-associated gastrointestinal distress. These discoveries highlight a critical role for midbrain kappa opioid receptor-expressing neurons and the downstream ventrolateral periaqueductal gray in opioid withdrawal-associated disruption of hedonic homeostasis and gastrointestinal regulation.
- 23 September 2025
- Published by Elsevier in The Journal of Pain
- Vol. 38, 105565
Cre-based functional profiling of RVM neurons implicates distinct populations in sensory-mediated behaviors
- 23 September 2025
- Published by Elsevier in The Journal of Pain
- Vol. 38, 105565
Cre-based functional profiling of RVM neurons implicates distinct populations in sensory-mediated behaviors
- Top Cited Papers
- 31 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 387 (6733) , eadn9390
Scratching promotes allergic inflammation and host defense via neurogenic mast cell activation
Itch is a dominant symptom in dermatitis, and scratching promotes cutaneous inflammation, thereby worsening disease. However, the mechanisms through which scratching exacerbates inflammation and whether scratching provides benefit to the host are largely unknown. We found that scratching was required for skin inflammation in mouse models dependent on FcεRI-mediated mast cell activation. Scratching-induced inflammation required pain-sensing nociceptors, the neuropeptide substance P, and the mast cell receptor MrgprB2. Scratching also increased cutaneous inflammation and augmented host defense to superficial Staphylococcus aureus infection. Thus, through the activation of nociceptor-driven neuroinflammation, scratching both exacerbated allergic skin disease and provided protection from S. aureus , reconciling the seemingly paradoxical role of scratching as a pathological process and evolutionary adaptation.
- 31 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 387 (6733) , eadn9390
Top Cited PapersScratching promotes allergic inflammation and host defense via neurogenic mast cell activation
Itch is a dominant symptom in dermatitis, and scratching promotes cutaneous inflammation, thereby worsening disease. However, the mechanisms through which scratching exacerbates inflammation and whether scratching provides benefit to the host are largely unknown. We found that scratching was required for skin inflammation in mouse models dependent on FcεRI-mediated mast cell activation. Scratching-induced inflammation required pain-sensing nociceptors, the neuropeptide substance P, and the mast cell receptor MrgprB2. Scratching also increased cutaneous inflammation and augmented host defense to superficial Staphylococcus aureus infection. Thus, through the activation of nociceptor-driven neuroinflammation, scratching both exacerbated allergic skin disease and provided protection from S. aureus , reconciling the seemingly paradoxical role of scratching as a pathological process and evolutionary adaptation.
- Open Access
- 27 September 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (39) , eadp6038
Kappa opioids inhibit spinal output neurons to suppress itch
Itch is a protective sensation that drives scratching. Although specific cell types have been proposed to underlie itch, the neural basis for itch remains unclear. Here, we used two-photon Ca 2+ imaging of the dorsal horn to visualize neuronal populations that are activated by itch-inducing agents. We identify a convergent population of spinal interneurons recruited by diverse itch-causing stimuli that represents a subset of neurons that express the gastrin-releasing peptide receptor (GRPR). Moreover, we find that itch is conveyed to the brain via GRPR-expressing spinal output neurons that target the lateral parabrachial nuclei. We then show that the kappa opioid receptor agonist nalfurafine relieves itch by selectively inhibiting GRPR spinoparabrachial neurons. These experiments provide a population-level view of the spinal neurons that respond to pruritic stimuli, pinpoint the output neurons that convey itch to the brain, and identify the cellular target of kappa opioid receptor agonists for the inhibition of itch.
- 27 September 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (39) , eadp6038
Open AccessKappa opioids inhibit spinal output neurons to suppress itch
Itch is a protective sensation that drives scratching. Although specific cell types have been proposed to underlie itch, the neural basis for itch remains unclear. Here, we used two-photon Ca 2+ imaging of the dorsal horn to visualize neuronal populations that are activated by itch-inducing agents. We identify a convergent population of spinal interneurons recruited by diverse itch-causing stimuli that represents a subset of neurons that express the gastrin-releasing peptide receptor (GRPR). Moreover, we find that itch is conveyed to the brain via GRPR-expressing spinal output neurons that target the lateral parabrachial nuclei. We then show that the kappa opioid receptor agonist nalfurafine relieves itch by selectively inhibiting GRPR spinoparabrachial neurons. These experiments provide a population-level view of the spinal neurons that respond to pruritic stimuli, pinpoint the output neurons that convey itch to the brain, and identify the cellular target of kappa opioid receptor agonists for the inhibition of itch.
- Open Access
- 19 March 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (4) , 113970
Long-range inhibitory neurons mediate cortical neurovascular coupling
- 19 March 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (4) , 113970
Open AccessLong-range inhibitory neurons mediate cortical neurovascular coupling
- Open Access
- 28 February 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (3) , 113829
The functional and anatomical characterization of three spinal output pathways of the anterolateral tract
- 28 February 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (3) , 113829
Open AccessThe functional and anatomical characterization of three spinal output pathways of the anterolateral tract
- Open Access
- 26 February 2024
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 13
Molecular identification of wide-field amacrine cells in mouse retina that encode stimulus orientation
Summary Visual information processing is sculpted by a diverse group of inhibitory interneurons in the retina called amacrine cells. Yet, for most of the >60 amacrine cell types, molecular identities and specialized functional attributes remain elusive. Here, we developed an intersectional genetic strategy to target a group of wide-field amacrine cells (WACs) in mouse retina that co-express the transcription factor Bhlhe22 and the Kappa Opioid Receptor (KOR; B/K WACs). B/K WACs feature straight, unbranched dendrites spanning over 0.5 mm (∼15° visual angle) and produce non-spiking responses to either light increments or decrements. Two-photon dendritic population imaging reveals Ca2+ signals tuned to the physical orientations of B/K WAC dendrites, signifying a robust structure-function alignment. B/K WACs establish divergent connections with multiple retinal neurons, including unexpected connections with non-orientation-tuned ganglion cells and bipolar cells. Our work sets the stage for future comprehensive investigations of the most enigmatic group of retinal neurons: WACs.
- 26 February 2024
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 13
Open AccessMolecular identification of wide-field amacrine cells in mouse retina that encode stimulus orientation
Summary Visual information processing is sculpted by a diverse group of inhibitory interneurons in the retina called amacrine cells. Yet, for most of the >60 amacrine cell types, molecular identities and specialized functional attributes remain elusive. Here, we developed an intersectional genetic strategy to target a group of wide-field amacrine cells (WACs) in mouse retina that co-express the transcription factor Bhlhe22 and the Kappa Opioid Receptor (KOR; B/K WACs). B/K WACs feature straight, unbranched dendrites spanning over 0.5 mm (∼15° visual angle) and produce non-spiking responses to either light increments or decrements. Two-photon dendritic population imaging reveals Ca2+ signals tuned to the physical orientations of B/K WAC dendrites, signifying a robust structure-function alignment. B/K WACs establish divergent connections with multiple retinal neurons, including unexpected connections with non-orientation-tuned ganglion cells and bipolar cells. Our work sets the stage for future comprehensive investigations of the most enigmatic group of retinal neurons: WACs.
- Open Access
Molecular identification of wide-field amacrine cells in mouse retina that encode stimulus orientation
SUMMARY: Visual information processing is sculpted by a diverse group of inhibitory interneurons in the retina called amacrine cells. Yet, for most of the >60 amacrine cell types, molecular identities and specialized functional attributes remain elusive. Here, we developed an intersectional genetic strategy to target a group of wide-field amacrine cells (WACs) in mouse retina that co-express the transcription factor Bhlhe22 and the Kappa Opioid Receptor (KOR; B/K WACs). B/K WACs feature straight, unbranched dendrites spanning over 0.5 mm (∼15° visual angle) and produce non-spiking responses to either light increments or decrements. Two-photon dendritic population imaging reveals Ca 2+ signals tuned to the physical orientations of B/K WAC dendrites, signifying a robust structure-function alignment. B/K WACs establish divergent connections with multiple retinal neurons, including unexpected connections with non-orientation-tuned ganglion cells and bipolar cells. Our work sets the stage for future comprehensive investigations of the most enigmatic group of retinal neurons: WACs.
Open AccessMolecular identification of wide-field amacrine cells in mouse retina that encode stimulus orientation
SUMMARY: Visual information processing is sculpted by a diverse group of inhibitory interneurons in the retina called amacrine cells. Yet, for most of the >60 amacrine cell types, molecular identities and specialized functional attributes remain elusive. Here, we developed an intersectional genetic strategy to target a group of wide-field amacrine cells (WACs) in mouse retina that co-express the transcription factor Bhlhe22 and the Kappa Opioid Receptor (KOR; B/K WACs). B/K WACs feature straight, unbranched dendrites spanning over 0.5 mm (∼15° visual angle) and produce non-spiking responses to either light increments or decrements. Two-photon dendritic population imaging reveals Ca 2+ signals tuned to the physical orientations of B/K WAC dendrites, signifying a robust structure-function alignment. B/K WACs establish divergent connections with multiple retinal neurons, including unexpected connections with non-orientation-tuned ganglion cells and bipolar cells. Our work sets the stage for future comprehensive investigations of the most enigmatic group of retinal neurons: WACs.
- Open Access
- 22 November 2023
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 8 (22)
Alleviation of neuropathic pain with neuropeptide Y requires spinal Npy1r interneurons that coexpress Grp
Neuropeptide Y targets the Y1 receptor (Y1) in the spinal dorsal horn (DH) to produce endogenous and exogenous analgesia. DH interneurons that express Y1 (Y1-INs; encoded by Npy1r ) are necessary and sufficient for neuropathic hypersensitivity after peripheral nerve injury. However, as Y1-INs are heterogenous in composition in terms of morphology, neurophysiological characteristics, and gene expression, we hypothesized that a more precisely defined subpopulation mediates neuropathic hypersensitivity. Using fluorescence in situ hybridization, we found that Y1-INs segregate into 3 largely nonoverlapping subpopulations defined by the coexpression of Npy1r with gastrin-releasing peptide ( Grp / Npy1r ), neuropeptide FF ( Npff / Npy1r ), and cholecystokinin ( Cck / Npy1r ) in the superficial DH of mice, nonhuman primates, and humans. Next, we analyzed the functional significance of Grp / Npy1r , Npff / Npy1r , and Cck / Npy1r INs to neuropathic pain using a mouse model of peripheral nerve injury. We found that chemogenetic inhibition of Npff / Npy1r -INs did not change the behavioral signs of neuropathic pain. Further, inhibition of Y1-INs with an intrathecal Y1 agonist, [Leu 31 , Pro 34 ]-NPY, reduced neuropathic hypersensitivity in mice with conditional deletion of Npy1r from CCK-INs and NPFF-INs but not from GRP-INs. We conclude that Grp / Npy1r -INs are conserved in higher order mammalian species and represent a promising and precise pharmacotherapeutic target for the treatment of neuropathic pain.
- 22 November 2023
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 8 (22)
Open AccessAlleviation of neuropathic pain with neuropeptide Y requires spinal Npy1r interneurons that coexpress Grp
Neuropeptide Y targets the Y1 receptor (Y1) in the spinal dorsal horn (DH) to produce endogenous and exogenous analgesia. DH interneurons that express Y1 (Y1-INs; encoded by Npy1r ) are necessary and sufficient for neuropathic hypersensitivity after peripheral nerve injury. However, as Y1-INs are heterogenous in composition in terms of morphology, neurophysiological characteristics, and gene expression, we hypothesized that a more precisely defined subpopulation mediates neuropathic hypersensitivity. Using fluorescence in situ hybridization, we found that Y1-INs segregate into 3 largely nonoverlapping subpopulations defined by the coexpression of Npy1r with gastrin-releasing peptide ( Grp / Npy1r ), neuropeptide FF ( Npff / Npy1r ), and cholecystokinin ( Cck / Npy1r ) in the superficial DH of mice, nonhuman primates, and humans. Next, we analyzed the functional significance of Grp / Npy1r , Npff / Npy1r , and Cck / Npy1r INs to neuropathic pain using a mouse model of peripheral nerve injury. We found that chemogenetic inhibition of Npff / Npy1r -INs did not change the behavioral signs of neuropathic pain. Further, inhibition of Y1-INs with an intrathecal Y1 agonist, [Leu 31 , Pro 34 ]-NPY, reduced neuropathic hypersensitivity in mice with conditional deletion of Npy1r from CCK-INs and NPFF-INs but not from GRP-INs. We conclude that Grp / Npy1r -INs are conserved in higher order mammalian species and represent a promising and precise pharmacotherapeutic target for the treatment of neuropathic pain.